Literature DB >> 11018044

SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985.

C Bjorbak1, H J Lavery, S H Bates, R K Olson, S M Davis, J S Flier, M G Myers.   

Abstract

During leptin signaling, each of the phosphorylated tyrosine residues on the long form of the leptin receptor (LRb) mediates distinct signals. Phosphorylated Tyr(1138) binds STAT3 to mediate its tyrosine phosphorylation and transcriptional activation, while phosphorylated Tyr(985) binds the tyrosine phosphatase SHP-2 and reportedly mediates both activation of ERK kinases and inhibition of LRb-mediated STAT3 activation. We show here that although mutation of Tyr(985) does not alter STAT3 signaling by erythropoietin receptor-LRb (ELR) chimeras in transfected 293 cells at short times of stimulation, this mutation enhances STAT3 signaling at longer times of stimulation (>6 h). These data suggest that Tyr(985) may mediate feedback inhibition of LRb signaling by an LRb-induced LRb inhibitor, such as SOCS3. Indeed, SOCS3 binds specifically to phosphorylated Tyr(985) of LRb, and SOCS3 fails to inhibit transcription by ELR following mutation of Tyr(985), suggesting that SOCS3 inhibits LRb signaling by binding to phosphorylated Tyr(985). Additionally, overexpression of SOCS3, but not SHP-2, impairs ELR signaling, and the overexpression of SHP-2 blunts SOCS3-mediated inhibition of ELR signaling. Thus, our data suggest that in addition to mediating SHP-2 binding and ERK activation during acute stimulation, Tyr(985) of LRb mediates feedback inhibition of LRb signaling by binding to LRb-induced SOCS3.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018044     DOI: 10.1074/jbc.M007577200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  163 in total

Review 1.  The central role of SOCS-3 in integrating the neuro-immunoendocrine interface.

Authors:  C J Auernhammer; S Melmed
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  Obesity, leptin, and Alzheimer's disease.

Authors:  Edward B Lee
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

3.  Grape seed proanthocyanidins and metformin act by different mechanisms to promote insulin signaling in rats fed high calorie diet.

Authors:  Baskaran Yogalakshmi; Saravanan Bhuvaneswari; S Sreeja; Carani Venkatraman Anuradha
Journal:  J Cell Commun Signal       Date:  2013-09-12       Impact factor: 5.782

4.  Leptin action via LepR-b Tyr1077 contributes to the control of energy balance and female reproduction.

Authors:  Christa M Patterson; Eneida C Villanueva; Megan Greenwald-Yarnell; Michael Rajala; Ian E Gonzalez; Natinder Saini; Justin Jones; Martin G Myers
Journal:  Mol Metab       Date:  2012-07-26       Impact factor: 7.422

5.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

6.  Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance.

Authors:  Louise E Olofsson; Elizabeth K Unger; Clement C Cheung; Allison W Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

7.  Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo.

Authors:  Yu Shi; Vijay K Yadav; Nina Suda; X Sherry Liu; X Edward Guo; Martin G Myers; Gerard Karsenty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-11       Impact factor: 11.205

Review 8.  Leptin signaling and leptin resistance.

Authors:  Yingjiang Zhou; Liangyou Rui
Journal:  Front Med       Date:  2013-04-12       Impact factor: 4.592

9.  Leptin signaling: A key pathway in immune responses.

Authors:  Claudio Procaccini; Elaine V Lourenco; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Signal Transduct Ther       Date:  2009-01-01

10.  Effects of chronic central leptin infusion on proopiomelanocortin and neurotensin gene expression in the rat hypothalamus.

Authors:  Abhiram Sahu
Journal:  Neurosci Lett       Date:  2008-05-28       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.